This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Frontotemporal dementia, wide, incl. Pick's disease
FTD_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
278 |
4. Check minimum number of eventsNone |
278 |
5. Include endpointsNone |
278 |
6. Filter based on genotype QC (FinnGen only) |
241 |
Control definitions (FinnGen only)
- Control exclude
- F5_DEMENTIA, G6_ALZHEIMER, G6_AD_STRICT
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Frontotemporal dementia, wide, incl. Pick's disease
based on the number of shared cases.
Similar with more cases:
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
- Organic, including symptomatic, mental disorders
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 241 | 105 | 136 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 69.39 | 69.33 | 69.43 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 247
- Matched controls
- 2470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
206.3
168
*
F03
ICD-10 Finland
Unspecified dementia
109.1
155.3
81
11
G31.0
ICD-10 Finland
Circumscribed brain atrophy
2418.3
141.0
123
*
N05AX08
ATC
risperidone; systemic
22.6
114.2
98
70
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
14.1
88.3
102
117
N05AH03
ATC
olanzapine; systemic
19.9
83.7
72
50
XA800
NOMESCO Finland
Neuropsychological investigation
21.8
73.6
59
35
N05AH04
ATC
quetiapine; oral
9.7
67.5
107
180
TAB00
NOMESCO Finland
Lumbar puncture
16.6
67.5
63
50
N03AG01
ATC
valproic acid; systemic, rectal
16.2
64.8
61
49
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
13.5
58.6
62
60
Z2445
NOMESCO Finland
Psychologist
21.8
57.3
45
25
P20
ICPC
Memory disturbance
7.9
52.6
96
184
P70
ICPC
Dementia
148.1
46.6
48
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.9
43.2
72
123
N06DX01
ATC
memantine; oral
109.6
42.4
45
5
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
10.2
41.4
52
63
F02.09
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
39.7
37
*
N06DA02
ATC
donepezil; oral
69.8
36.5
41
7
ZY010
NOMESCO Finland
Hospital outpatient
12.6
35.5
37
34
N05BA06
ATC
lorazepam; systemic, sublingual
8.7
33.5
47
65
F06.7
ICD-10 Finland
Mild cognitive disorder
11.5
32.6
36
36
N06DA03
ATC
rivastigmine; oral, transdermal
130.8
32.6
34
*
A28
ICPC
Limited function/disability NOS
4.5
28.4
100
324
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
23.3
22
*
N05BA04
ATC
oxazepam; oral
3.9
23.3
102
379
G30.1
ICD-10 Finland
Alzheimer disease with late onset
66.1
21.3
24
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.6
20.5
31
46
F02.00
ICD-10 Finland
Dementia in Pick's disease without additional symptoms
+∞
20.1
19
*
F0203, G310,
ICD-10 Finland
+∞
20.1
19
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
5.8
19.6
39
77
R41.3
ICD-10 Finland
Other amnesia
8.3
19.5
27
36
F0200, G310,
ICD-10 Finland
+∞
19.0
18
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
+∞
19.0
18
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
8.2
18.6
26
35
F0204, G310,
ICD-10 Finland
+∞
17.9
17
*
N06AX11
ATC
mirtazapine; oral
3.2
17.8
114
521
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
193.3
17.8
18
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
24.0
17.2
24
11
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.6
16.9
29
49
SPAT1234
SPAT
Support of social functional capacity
6.4
16.6
29
50
N06AB10
ATC
escitalopram; oral
3.7
16.6
63
207
AA1AD
NOMESCO Finland
CT of head and brain
3.0
15.8
117
572
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
7.0
15.7
25
39
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
13.0
15.5
27
23
R41.0
ICD-10 Finland
Disorientation, unspecified
6.8
15.3
25
40
IGY02
NOMESCO Finland
Psychiatric monitoring contact
18.0
15.1
23
14
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.0
14.8
34
76
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
38.6
14.7
18
5
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.3
14.5
42
113
F02.04
ICD-10 Finland
Dementia in Pick's disease other additional symptoms of mixed type
+∞
13.7
13
*
IAB14
NOMESCO Finland
Geriatric psychiatry consultation
147.8
13.6
14
*
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
147.8
13.6
14
*
SPAT1216
SPAT
Assessment of functional ability
3.2
13.4
64
241
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.5
13.2
27
54
N05AX12
ATC
aripiprazole; systemic
14.1
13.2
22
17
ZY000
NOMESCO Finland
Hospital inpatient
30.3
13.1
17
6
P29
ICPC
Psychological sympt/compl other
5.9
12.9
24
44
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
136.7
12.6
13
*
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
136.7
12.6
13
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.6
12.5
25
49
N06AX26
ATC
vortioxetine; oral
5.7
12.3
24
46
F29
ICD-10 Finland
Unspecified nonorganic psychosis
12.0
11.8
21
19
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.9
11.7
27
60
IGY99
NOMESCO Finland
Other psychiatric treatment contact
68.3
11.7
13
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
68.3
11.7
13
*
RT250, ,
NOMESCO Finland
+∞
11.5
11
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.9
11.4
37
108
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
11.1
76
346
A04
ICPC
Weakness/tiredness general
3.0
11.0
56
217
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
16.5
11.0
17
11
N05AD01
ATC
haloperidol; systemic
8.6
10.9
23
29
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
15.1
10.6
17
12
Z2446
NOMESCO Finland
Social worker
4.1
10.5
31
84
G30.8
ICD-10 Finland
Other Alzheimer disease
114.7
10.5
11
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
+∞
10.5
10
*
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
10.5
10
*
F0202, G310,
ICD-10 Finland
+∞
10.5
10
*
F0201, G310,
ICD-10 Finland
+∞
10.5
10
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
13.9
10.3
17
13
N05CD07
ATC
temazepam; oral
3.1
10.3
51
194
F05.9
ICD-10 Finland
Delirium, unspecified
9.8
10.2
20
22
F22.0
ICD-10 Finland
Delusional disorder
21.1
9.9
14
7
SPAT1053
SPAT
Memory test
2.9
9.7
54
219
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.2
9.5
20
41
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
22.8
9.4
13
6
RT150, ,
NOMESCO Finland
+∞
9.4
9
*
F06.4
ICD-10 Finland
Organic anxiety disorder
+∞
9.4
9
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
8.9
9.3
19
23
N06AX16
ATC
venlafaxine; oral
3.0
9.2
45
170
N99
ICPC
Neurological disease other
16.4
9.1
14
9
N03AX09
ATC
lamotrigine; oral
7.3
9.1
21
31
N06AB04
ATC
citalopram; systemic
2.6
9.0
66
307
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
13.4
8.5
14
11
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
8.4
8
*
N05BA01
ATC
diazepam; systemic, rectal
2.7
8.1
48
200
L28
ICPC
Limited function/disability (L)
2.4
7.9
67
332
P28
ICPC
Limited function/disability (P)
46.5
7.8
9
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
7.8
99
582
-, ,
ICD-10 Finland
8.5
7.7
16
20
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.4
7.6
29
94
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
82.5
7.5
8
*
P99
ICPC
Psychological disorders other
8.8
7.4
15
18
F02.0
ICD-10 Finland
Dementia in Pick disease
+∞
7.3
7
*
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
7.3
7
*
F064, G310,
ICD-10 Finland
+∞
7.3
7
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.0
7.2
21
56
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
31.0
7.2
9
*
S01.0
ICD-10 Finland
Open wound of scalp
3.1
7.2
32
114
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
12.5
7.2
12
10
N05AN01
ATC
lithium; oral
10.5
7.1
13
13
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.4
7.1
27
87
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
4.6
7.1
17
39
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.3
7.0
15
501
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
6.8
90
531
A06AD11
ATC
lactulose; oral
2.4
6.8
51
238
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
41.2
6.8
8
*
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
23.2
6.7
9
*
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
23.2
6.7
9
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
8.2
6.7
14
18
SPAT1101
SPAT
Orthostatic test
3.9
6.6
20
55
U04
ICPC
Incontinence urine
3.3
6.6
26
86
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
71.6
6.5
7
*
N06DA04
ATC
galantamine; oral
71.6
6.5
7
*
Z2221
NOMESCO Finland
Medical doctor
2.1
6.5
77
436
N05AH02
ATC
clozapine; systemic
14.8
6.4
10
7
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
14.8
6.4
10
7
N19
ICPC
Speech disorder
14.8
6.4
10
7
F31.8
ICD-10 Finland
Other bipolar affective disorders
11.4
6.4
11
10
WYA20
NOMESCO Finland
Home visit
7.3
6.3
14
20
F060, G310,
ICD-10 Finland
+∞
6.3
6
*
F020, G310,
ICD-10 Finland
+∞
6.3
6
*
F02.01
ICD-10 Finland
Dementia in Pick's disease has other additional symptoms, mainly paranoidism
+∞
6.3
6
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.3
6.2
16
39
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
8.9
6.1
12
14
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
5.8
6.1
16
29
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
10.4
6.1
11
11
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
6.1
50
243
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.7
6.0
19
54
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
46
40
13.90
46.06
1.1
1.2
1.97
21.10
e6/l
0.53
33
29
45
42
12.88
43.02
1.1
1.3
140.39
94.61
e6/l
0.21
33
31
99
391
3.56
20.12
2.0
1.8
1345.60
1218.36
nmol/l
0.67
78
291
20
46
4.64
8.31
1.2
1.4
—
—
—
0
0
20
46
4.64
8.31
1.2
1.4
—
—
—
0
0
42
168
2.81
7.67
2.7
1.8
1.45
1.72
%
1.40
35
139
146
1007
2.10
7.40
2.9
2.2
90.67
96.26
pmol/l
0.90
81
513
86
490
2.16
7.20
3.1
3.4
2.45
2.47
mmol/l
0.52
70
435
120
778
2.05
7.11
2.5
3.9
2.35
2.35
mmol/l
0.10
102
702
55
261
2.42
7.09
9.9
8.1
—
—
—
0
0
47
215
2.46
6.53
2.6
2.6
36.76
34.24
u/l
0.15
41
173
58
298
2.24
6.18
2.0
2.0
—
—
—
0
0
78
469
1.97
5.42
5.1
4.7
1.02
1.02
kg/l
0.03
42
324
72
422
2.00
5.38
3.3
3.3
1.35
1.03
e6/l
0.56
37
236
52
882
0.48
5.28
1.8
2.0
1.59
1.30
mmol/l
1.54
46
710
58
316
2.09
5.27
1.9
1.9
—
—
—
0
0
100
675
1.81
4.75
2.0
1.7
18.06
21.13
nmol/l
1.40
91
556
67
410
1.87
4.31
1.9
1.9
—
—
—
0
0
102
709
1.75
4.29
2.6
2.2
422.68
214.80
u/l
0.89
91
666
9
15
6.18
3.85
1.0
1.1
—
—
—
0
0
19
72
2.78
3.83
1.2
1.2
—
—
—
0
0
133
1016
1.67
3.82
4.3
5.2
35.38
35.01
g/l
0.30
116
952
55
844
0.55
3.70
3.2
4.3
5.50
9.38
mg/mmol
1.14
38
532
114
847
1.64
3.58
3.9
3.6
—
—
—
0
0
10
293
0.31
3.52
3.5
5.4
39.40
32.04
%
—
5
182
61
388
1.76
3.39
3.3
3.4
6.17
2.35
e6/l
0.65
25
202
36
604
0.53
3.19
4.5
3.8
0.00
0.01
estimate
0.50
14
206
134
1059
1.58
3.12
7.5
6.5
1.20
1.21
mmol/l
0.45
119
965
9
21
4.41
3.02
1.0
1.1
—
—
—
0
0
93
683
1.58
2.93
4.0
3.6
0.24
0.56
e6/l
1.80
71
511
20
93
2.25
2.69
1.9
3.7
4.12
4.35
pmol/l
0.24
13
84
28
154
1.92
2.46
2.0
1.7
—
—
—
0
0
19
362
0.49
2.44
1.3
1.3
18.23
41.19
iu/ml
—
6
130
174
1940
0.65
2.35
4.1
5.7
1.42
1.46
mmol/l
0.53
152
1758
140
1162
1.47
2.32
7.5
7.4
1.21
1.21
mmol/l
0.38
115
990
0
62
0.00
2.26
0.0
1.6
—
—
—
0
0
15
67
2.32
2.22
4.2
3.7
2.00
1.98
index
—
8
43
173
1924
0.66
2.19
6.5
7.5
39.57
40.39
mmol/mol
0.52
160
1789
46
305
1.62
2.16
9.7
7.2
0.97
0.73
mmol/l
0.09
38
256
0
56
0.00
2.09
0.0
1.3
—
—
—
0
0
7
20
3.57
2.07
1.0
1.1
—
—
—
0
0
66
481
1.51
2.06
1.6
1.8
420.25
437.08
pmol/l
0.21
55
394
171
1505
1.44
1.89
5.5
4.3
14.34
15.10
pmol/l
3.23
158
1344
34
216
1.67
1.89
3.3
2.5
6.91
8.41
ug/l
0.17
25
191
169
1869
0.70
1.82
3.6
4.8
1.37
1.27
mmol/l
1.16
145
1682
19
324
0.55
1.72
1.4
1.4
1.79
11.25
u/ml
—
7
123
10
206
0.46
1.62
1.1
1.4
—
—
—
0
0
183
1984
0.70
1.60
5.2
6.8
2.65
2.56
mmol/l
0.57
162
1809
80
985
0.72
1.59
2.5
2.8
—
—
estimate
—
0
0
178
1935
0.71
1.54
22.3
19.1
78.00
73.74
ml/min/173m2
2.73
168
1806
180
1949
0.72
1.46
5.2
5.9
6.19
6.10
mmol/l
0.36
164
1775
180
1948
0.72
1.44
4.2
5.8
4.57
4.47
mmol/l
0.62
157
1782
81
652
1.36
1.43
5.5
4.3
0.00
0.01
estimate
0.50
15
232
16
89
1.85
1.41
2.3
2.0
0.00
0.00
g/l
-0.00
11
75
17
99
1.77
1.31
2.1
2.2
1.68
0.44
g/l
0.52
12
85
24
158
1.57
1.20
7.0
7.4
25.86
24.93
mmol/l
0.50
24
158
179
1648
1.31
1.11
6.9
9.1
79.60
82.15
u/l
0.32
160
1553
53
416
1.35
1.09
2.8
3.3
0.81
0.82
mmol/l
0.25
46
396
196
1832
1.34
1.06
6.7
5.4
2.48
2.02
mu/l
0.50
176
1645
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
0
29
0.00
0.98
0.0
1.2
—
5.33
—
0
12
0
30
0.00
0.98
0.0
1.3
—
—
—
0
0
0
30
0.00
0.98
0.0
1.3
—
—
—
0
0
0
30
0.00
0.98
0.0
1.3
—
—
—
0
0
0
30
0.00
0.98
0.0
1.3
—
—
—
0
0
108
945
1.25
0.97
2.8
2.3
—
—
—
0
0
0
31
0.00
0.97
0.0
1.3
—
—
—
0
0
26
184
1.46
0.96
3.2
3.8
81.94
86.79
ng/l
0.17
18
160
127
1133
1.25
0.96
4.9
4.3
0.00
0.02
estimate
0.50
15
243
49
608
0.76
0.95
2.4
3.1
344.71
367.13
umol/l
0.76
35
515
70
583
1.28
0.95
3.2
2.2
2.91
3.01
mg/l
0.07
63
506
16
102
1.61
0.93
2.1
1.9
9.27
10.50
g/l
—
10
90
75
877
0.79
0.91
2.6
3.3
756.72
1564.42
ng/l
3.25
65
754
47
374
1.32
0.89
11.0
6.6
106.36
104.05
mmol/l
2.74
47
374
125
1122
1.23
0.87
4.9
4.3
0.00
6.20
estimate
0.50
16
262
18
121
1.53
0.85
1.8
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
81
1.64
0.83
2.2
2.5
0.38
0.40
iu/ml
—
8
45
123
1109
1.22
0.80
5.0
4.3
0.00
0.00
estimate
-0.00
16
257
0
24
0.00
0.79
0.0
1.8
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
0
25
0.00
0.79
0.0
1.3
—
2.13
—
0
8
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
19
132
1.48
0.78
1.8
2.5
—
14.15
—
0
6
16
107
1.53
0.78
2.1
1.9
3.55
3.09
g/l
0.60
11
96
205
1954
1.29
0.76
22.0
18.8
33.63
26.02
mg/l
1.66
170
1654
23
307
0.72
0.73
3.1
4.8
241.39
240.85
u/l
0.01
23
292
16
227
0.68
0.72
1.3
1.3
—
—
—
0
0
13
190
0.67
0.68
1.5
1.5
—
—
—
0
0
134
1233
1.19
0.66
5.1
3.6
57.26
56.06
u/l
0.03
120
1124
133
1227
1.18
0.63
9.5
10.3
4.46
4.18
e9/l
0.61
114
1058
5
30
1.68
0.61
1.4
1.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.7
—
324.77
—
0
20
0
20
0.00
0.60
0.0
1.5
—
13.35
—
0
20
13
89
1.49
0.59
2.7
3.1
1.03
2.63
ratio
—
6
50
0
23
0.00
0.58
0.0
1.1
—
193.31
—
0
7
5
86
0.57
0.57
1.0
1.0
—
—
—
0
0
16
116
1.41
0.56
2.1
1.9
3.97
4.34
g/l
1.40
11
105
16
116
1.41
0.56
2.1
1.9
7.78
7.42
g/l
0.26
11
105
16
116
1.41
0.56
2.1
1.9
4.62
3.89
g/l
0.42
11
105
101
920
1.17
0.54
2.6
2.5
75.71
80.04
nmol/l
0.89
89
816
23
179
1.31
0.53
1.9
2.9
79.83
60.20
ml/min/173m2
—
6
79
83
915
0.86
0.50
5.4
6.1
2.83
2.64
ug/l
0.09
74
803
7
48
1.47
0.47
2.4
3.9
36.11
28.24
mg/l
—
7
37
22
174
1.29
0.47
1.6
1.5
—
—
—
0
0
19
149
1.30
0.43
3.4
2.6
0.59
0.64
%
0.32
19
149
5
32
1.57
0.42
1.4
1.4
—
—
—
0
0
8
58
1.39
0.42
1.0
1.3
—
—
—
0
0
91
837
1.14
0.41
5.3
4.3
0.00
0.02
estimate
0.78
15
216
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
13.62
—
0
16
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
19
151
1.28
0.40
3.5
2.6
1.22
1.06
%
0.64
19
151
9
68
1.34
0.38
1.0
1.3
—
—
—
0
0
30
254
1.21
0.37
3.8
3.7
—
—
—
0
0
51
454
1.16
0.37
4.5
4.1
66.30
215.93
ng/l
1.53
46
393
49
539
0.89
0.28
2.9
3.4
1.04
0.82
ug/l
0.29
40
368
159
1535
1.10
0.27
3.4
4.7
13.56
14.02
mm/h
0.13
144
1416
8
67
1.20
0.26
1.5
1.5
—
—
—
0
0
98
930
1.09
0.24
4.3
4.3
27.51
42.12
ng/l
1.67
76
752
210
2062
1.12
0.23
29.1
22.9
139.85
139.64
mmol/l
0.50
204
2029
210
2063
1.12
0.22
28.2
23.1
3.97
4.01
mmol/l
1.46
204
2027
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
24
212
1.15
0.20
2.3
2.9
65.79
66.38
g/l
0.15
17
194
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
186.56
—
0
14
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
67
711
0.92
0.20
2.8
2.7
47.17
69.02
u/l
1.68
60
654
137
1326
1.07
0.19
7.6
5.1
7.02
6.85
mmol/l
0.41
126
1267
203
2062
0.91
0.18
12.4
13.8
23.37
25.26
u/l
1.20
191
1994
127
1231
1.07
0.16
4.5
7.3
10.54
12.18
umol/l
1.41
117
1166
8
69
1.16
0.16
1.4
1.2
—
—
—
0
0
8
69
1.16
0.16
1.4
1.2
—
—
—
0
0
8
73
1.10
0.16
1.5
1.5
—
—
—
0
0
210
2077
1.07
0.11
28.5
25.7
75.79
83.35
umol/l
4.49
204
2059
5
47
1.07
0.09
1.4
1.6
—
—
—
0
0
5
63
0.79
0.08
1.0
2.3
127.40
128.57
g/l
—
5
46
6
71
0.84
0.07
1.7
1.7
—
—
—
0
0
7
81
0.86
0.07
1.7
1.8
—
—
—
0
0
49
507
0.96
0.06
1.7
1.7
1.42
1.72
mg/l
0.41
38
410
55
536
1.03
0.05
2.2
2.4
—
—
—
0
0
43
441
0.97
0.03
1.3
1.3
0.69
1.25
u/ml
—
9
119
74
728
1.02
0.03
4.4
4.9
21.69
22.11
%
0.08
33
373
87
879
0.98
0.02
3.4
3.0
104.86
155.43
ug/l
2.35
78
814
209
2091
1.00
0.00
33.6
28.4
4.34
4.45
e12/l
2.30
204
2036
209
2091
1.00
0.00
33.6
28.4
244.47
240.42
e9/l
0.36
204
2045
43
429
1.00
0.00
1.8
2.6
11.81
12.91
umol/l
0.52
37
400
40
405
0.99
0.00
1.7
2.5
2.26
2.26
g/l
0.02
31
377
18
184
0.98
0.00
1.7
3.0
150.22
234.29
ng/l
0.85
18
165
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
2.0
—
119.67
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.9
—
199.75
—
0
8
17
170
1.00
-0.00
3.4
3.3
132.12
127.14
g/l
0.46
17
164
0
8
0.00
-0.00
0.0
1.1
—
39.58
—
0
8
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
5
57
0.87
-0.00
1.6
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
9.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
9.90
—
0
5
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
-0.00
0.0
1.9
—
148.57
—
0
7
5
58
0.86
-0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
9.16
—
0
7
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
7
73
0.96
-0.00
1.7
1.6
—
—
—
0
0
12
120
1.00
-0.00
1.4
2.0
1.86
1.53
g/l
0.43
12
111
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
1.30
—
0
5
8
86
0.93
-0.00
1.9
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: FTD_WIDE – Frontotemporal dementia, wide, incl. Pick's disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).